Aetion Secures $11.2M in Series A Funding

aetionAetion, a NYC-based healthcare technology company, secured $11.2m in Series A funding.

The round was led by Flare Capital Partners and joined by Lakestar.

The company intends to use the funds to extend the capabilities of its platform, as well as expand and commercialize its solutions.

Led by Jeremy A. Rassen, Sc.D., co-founder, president and chief scientific officer, and Sebastian Schneeweiss, M.D., Sc.D., co-founder and science lead, Aetion, and professor of medicine and epidemiology, Harvard Medical School, Aetion provides payer/provider, biopharma and medical device customers with a platform which combines science with computing technology to allow them to gain insights into the clinical and financial status of a population, measure and compare the effectiveness and value of treatments and provider practices and realize value-based contracting.



Join the discussion